Supernus Pharmaceuticals Inc.

SUPN | NASDAQ

Price Alert Chart Builder DCF Calculator

$42.78

+$0.78 (+1.86%)

At close: Sep 21, 2026, 4:00 PM ET

$42.78

$0 (0.00%)

After-hours: Sep 21, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-38.55M	73.87M	1.32M	60.71M	53.42M	126.95M
Depreciation & Amortization	90.03M	80.41M	84.86M	85.54M	32.6M	18.14M
Stock-Based Compensation	33.05M	27.76M	26.76M	17.57M	17.91M	16.56M
Other Working Capital	-20.79M	-4.92M	2.28M	29.14M	-3.9M	-56K
Other Non-Cash Items	32.75M	12.11M	33M	3.57M	24.62M	12.69M
Deferred Income Tax	5.21M	-20.14M	-25.71M	-26.32M	-4.99M	568K
Change in Working Capital	-75.16M	-2.05M	-9.14M	-24.24M	3.57M	-36.52M
Operating Cash Flow	47.33M	171.95M	111.09M	116.83M	127.13M	138.4M
Capital Expenditures	-1.34M	-725K	-551K	-412K	-2.05M	-3.45M
Cash Acquisitions	-293.09M	n/a	n/a	-14K	-311.69M	-313.54M
Purchase of Investments	-475.94M	-688.01M	-101.62M	-406.99M	-311.57M	-95.89M
Sales Maturities Of Investments	774.92M	498.86M	370.9M	190.74M	530.51M	378.42M
Other Investing Acitivies	-439K	9K	n/a	14K	12.89M	-241K
Investing Cash Flow	4.11M	-189.87M	268.73M	-216.66M	-81.91M	-34.7M
Debt Repayment	n/a	n/a	-402.5M	n/a	-137.52M	-802K
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-28.49M	-2.72M	-1.99M	-22.9M	n/a	n/a
Financial Cash Flow	9.13M	12.19M	-397.88M	-10.48M	-130.42M	3.56M
Net Cash Flow	60.57M	-5.72M	-18.07M	-110.31M	-85.21M	107.26M
Free Cash Flow	45.99M	171.23M	110.53M	116.41M	125.08M	134.95M
Adj. Free Cash Flow	12.94M	143.47M	83.78M	98.85M	107.17M	118.39M
Maintenance CapEx	n/a	n/a	-551K	n/a	n/a	n/a
Growth CapEx	-1.34M	-725K	n/a	-412K	-2.05M	-3.45M
Owner Earnings	47.33M	171.95M	110.53M	116.83M	127.13M	138.4M